DENTSPLY SIRONA director reports equity grants and gifts
DENTSPLY SIRONA Inc. director Gregory T. Lucier reported a mix of equity awards and family wealth transfers in company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DENTSPLY SIRONA Inc. director Gregory T. Lucier reported a mix of equity awards and family wealth transfers in company stock. He made bona fide gifts of 38,382 shares of Common Stock and 10,900 stock options to a family partnership associated with a trust benefiting him, with his spouse as general partner.
At the same time, he received matching direct awards: 38,382 Restricted Stock Units that vest in full one year from the grant date and 10,900 Non‑Qualified Stock Options with a $9.64 exercise price that vest in one year and expire in 2036. After these transactions, indirect Common Stock holdings reported include 65,000 shares held by a trust and 21,000 shares held in an IRA, while the family partnership is shown with 63,283.284 shares. These moves reflect compensation grants and estate or family planning activity rather than open‑market buying or selling.
Insights
Lucier reported equity grants and family gifts, with no market trades.
The filing shows Gregory T. Lucier, a director of DENTSPLY SIRONA, receiving equity compensation while transferring existing interests to a family partnership. He gifted 38,382 Common shares and 10,900 stock options as bona fide gifts, not sales for cash.
Concurrently, he was granted 38,382 RSUs and 10,900 Non‑Qualified Stock Options at an exercise price of $9.64, both vesting in one year. Footnotes note that the family partnership includes a trust for his benefit and that he disclaims beneficial ownership beyond his pecuniary interest. Overall, these are routine compensation and estate‑planning moves with neutral investment signal.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 10,900 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) | 10,900 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) | 10,900 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 38,382 | $0.00 | $0.00 |
| Gift | Common Stock | 38,382 | $0.00 | $0.00 |
| Gift | Common Stock | 38,382 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.
- F2. Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose.
- F3. Stock Options vest in full one (1) year from date of grant.
- F4. Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs.
Key Figures
Key Terms
Restricted Stock Units (RSUs) financial
Non-Qualified Stock Options (NQSOs) financial
family partnership financial
pecuniary interest financial
Section 16 of the Exchange Act regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did XRAY director Gregory Lucier report in this Form 4?
What are the terms of Gregory Lucier’s new RSU award at DENTSPLY SIRONA (XRAY)?
What are the key details of the Non‑Qualified Stock Options reported for XRAY?
How are Gregory Lucier’s indirect holdings in DENTSPLY SIRONA (XRAY) structured after these transactions?
Does the Form 4 for XRAY indicate any pre‑planned trading or 10b5‑1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.